Pennsylvania Jury Slams Ethicon With $41M Verdict In Mesh Case
Executive Summary
Johnson & Johnson subsidiary Ethicon has been ordered to pay $41m to a plaintiff who says she was injured by the company’s pelvic mesh products.
You may also be interested in...
Philly Pelvic Mesh Trial Ends In Largest Verdict Against Ethicon
A Philadelphia jury awarded $57m to a woman who says she was injured by Ethicon pelvic mesh products in the fifth judgement against the company in the city’s Court of Common Pleas.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.